Is it Better to Shine a Light, or Rather to Curse the Darkness? Cerebral Near-Infrared Spectroscopy and Cardiac Surgery
EDITORIAL
World's Largest Resource for Cardiovascular Perfusion
EDITORIAL
This study was designed to evaluate the efficacy of autologous platelet gel and fibrin sealant in unilateral TKA.
This article comprehensively reviews the modern research progress of heparin compounds; discusses the structure, preparation, and adverse reactions of heparin; emphasizes the pharmacological activity and clinical application of heparin; reveals the possible mechanism of the therapeutic effect of heparin in related clinical applications; provides evidence support for the clinical application of heparin; and hints on the significance of exploring the wider application fields of heparin.
After withdrawal of aprotinin in 2008 only tranexamic acid (TxA, Cyclocapron, Pfitzer, Germany) remains available as antihyperfibrinolytic agent in Europe.